• Rational identification of small molecules derived from 9,10-dihydrophenanthrene as potential inhibitors of 3CLpro enzyme for COVID-19 therapy: a computer-aided drug design approach

    1 month ago - By Springer

    Abstract
    Small molecules such as 9,10-dihydrophenanthrene derivatives have remarkable activity toward inhibition of SARS-CoV-2 3CL pro and COVID-19 proliferation, which show a strong correlation between their structures and bioactivity. Therefore, these small compounds could be suitable for clinical pharmaceutical use against COVID-19. The objective of this study was to remodel the structures of 9,10-dihydrophenanthrene derivatives to achieve a powerful biological activity against 3CL pro and favorable pharmacokinetic properties for drug design and discovery. Therefore, by the use of...
    Read more ...

     

  • Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2

    1 month ago - By Springer

    Abstract
    The unprecedented outbreak of the severe acute respiratory syndrome Coronavirus-2, across the globe, triggered a worldwide uproar in the search for immediate treatment strategies. With no specific drug and not much data available, alternative approaches such as drug repurposing came to the limelight. To date, extensive research on the repositioning of drugs has led to the identification of numerous drugs against various important protein targets of the coronavirus strains, with hopes of the drugs working against the major variants of concerns of the virus. Advancements in...
    Read more ...